Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Parkinson's Disease
78%
Neurodegeneration with Brain Iron Accumulation
33%
Pantothenate Kinase-associated Neurodegeneration
25%
Alpha-synuclein (α-syn)
24%
Parkinson's Progression Markers Initiative
22%
Deep Brain Stimulation
21%
Huntington's Disease
17%
Neurodegeneration
16%
WDR45B
15%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
15%
Subthalamic nucleus
14%
Cardiac Magnetic Resonance Imaging (cMRI)
14%
Globus Pallidus Internus
13%
Leucine-rich Repeat Kinase 2 (LRRK2)
12%
Beta-propeller Protein-associated Neurodegeneration
12%
Healthy Controls
12%
Seed Amplification Assay
11%
Dystonia
11%
Globus Pallidus
10%
Pallidal
10%
Pantothenate
9%
Basal Ganglia
9%
Clinical Characteristics
8%
Parkinson Patients
8%
Idiopathic Parkinson's Disease
8%
X-linked Dominant
8%
Clinical Features
8%
Advanced PD
7%
PLA2G6-associated Neurodegeneration
7%
Parkinson's Disease Biomarkers
7%
Non-manifesting Carriers
7%
Clinical Practice Guidelines
7%
Metabolism
7%
Pattern Recognition
7%
Imaging Patterns
7%
4′-phosphopantetheine
7%
Pallidal Stimulation
7%
Laboratory Investigation
7%
Disease Progression
6%
Unified Parkinson's Disease Rating Scale (UPDRS)
6%
Patients with Parkinson's Disease
6%
Cognitive Impairment
6%
Brain Iron
6%
Synucleinopathy
6%
Dopamine Transporter
6%
L-DOPA
6%
Cerebrospinal Fluid
6%
Coenzyme A
6%
Gait
6%
Motor Score
5%
Neuroscience
Parkinson's Disease
100%
Deep Brain Stimulation
43%
Pantothenate Kinase-Associated Neurodegeneration
43%
Huntington's Disease
24%
Globus pallidus
23%
Subthalamic Nucleus
22%
Genetics
22%
Biological Marker
18%
Neurodegeneration
15%
Alpha-Synuclein
14%
Synuclein
12%
Magnetic Resonance Imaging
12%
Parkinsonism
10%
L-DOPA
10%
Dystonia
10%
Dopaminergic
9%
Gait
9%
Dyskinesia
9%
Dopamine Transporter
9%
Placebo
9%
Basal Ganglia
8%
Stereotypic Movement Disorder
8%
Randomized Controlled Trial
7%
Neurodegenerative Disorder
7%
Cognitive Disorders
7%
Quality of Life
6%
Nucleus
5%
Single-Photon Emission Computed Tomography
5%
Medicine and Dentistry
Pantothenate Kinase-Associated Neurodegeneration
33%
Diseases
33%
Parkinson's Disease
30%
Neurodegeneration
19%
Deep Brain Stimulation
17%
Globus pallidus
16%
Subthalamic Nucleus
14%
Basal Ganglia
10%
Dystonia
9%
Gait
9%
Iron
9%
Magnetic Resonance Imaging
8%
Synuclein
7%
Pantothenic Acid
7%
COVID-19
7%
Disease Exacerbation
6%
Dopamine Transporter
6%
Levodopa
5%
Biological Marker
5%